Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Domo, Maintains $30 Price Target By Benzinga Newsdesk Today, 1:17 PM JMP Securities analyst Patrick Walravens reiterates Domo (NASDAQ:DOMO) with a Market Outperform and maintains $30 price target. DOMO
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Aviat Networks, Maintains $50 Price Target By Benzinga Newsdesk Today, 1:17 PM JMP Securities analyst Erik Suppiger reiterates Aviat Networks (NASDAQ:AVNW) with a Market Outperform and maintains $50 price target. AVNW
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on SentinelOne, Maintains $19 Price Target By Benzinga Newsdesk Today, 1:17 PM Needham analyst Alex Henderson reiterates SentinelOne (NYSE:S) with a Buy and maintains $19 price target. S
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Medalist Diversified REIT, Maintains $1.25 Price Target By Benzinga Newsdesk Today, 1:17 PM EF Hutton analyst Gaurav Mehta reiterates Medalist Diversified REIT (NASDAQ:MDRR) with a Buy and maintains $1.25 price target. MDRR
Read More 2 minute read Analyst Color Analyst Ratings News Reiteration Tech Fintech Stock Plunges 15% In A Day Amid SVB Fallout — Analyst Says Time To Buy By Shanthi Rexaline Today, 1:17 PM Bill Holdings Inc. BILL
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Strong Buy on Infinera, Maintains $15 Price Target By Benzinga Newsdesk Today, 1:17 PM Needham analyst Alex Henderson reiterates Infinera (NASDAQ:INFN) with a Strong Buy and maintains $15 price target. INFN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Engagesmart, Maintains $40 Price Target By Benzinga Newsdesk Today, 1:17 PM Needham analyst Scott Berg reiterates Engagesmart (NYSE:ESMT) with a Buy and maintains $40 price target. ESMT
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Janux Therapeutics, Maintains $35 Price Target By Benzinga Newsdesk Today, 1:17 PM HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Janux Therapeutics (NASDAQ:JANX) with a Buy and maintains $35 price target. JANX
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Verona Pharma, Maintains $32 Price Target By Benzinga Newsdesk Today, 1:17 PM HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Verona Pharma (NASDAQ:VRNA) with a Buy and maintains $32 price target. VRNA
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Largo, Maintains $17 Price Target By Benzinga Newsdesk Today, 1:17 PM HC Wainwright & Co. analyst Heiko Ihle reiterates Largo (NASDAQ:LGO) with a Buy and maintains $17 price target. LGO